• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Prenetics Global Limited - Class A Ordinary Share (NQ:PRE)

    18.67 +0.03 (+0.16%)
    Streaming Delayed Price Updated: 11:57 AM EDT, Aug 3, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 38,098
    Open 19.45
    Bid (Size) 18.30 (100)
    Ask (Size) 18.67 (100)
    Prev. Close 18.64
    Today's Range 18.41 - 19.45
    52wk Range 7.175 - 23.63
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF)
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue
    From Prenetics Global Limited
    Via GlobeNewswire

    Performance

    YTD
    +18.3%
    +18.3%
    1 Month
    +6.7%
    +6.7%
    3 Month
    +13.2%
    +13.2%
    6 Month
    -3.8%
    -3.8%
    1 Year
    +138.9%
    +138.9%

    More News

    Read More
    News headline image
    Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta Expansion
    From Prenetics Global Limited
    Via GlobeNewswire
    Prenetics Global Ltd. (NASDAQ:PRE) Reports Q4 Revenue Beat and Narrower Loss on IM8 Strength ↗
    Via Chartmill
    News headline image
    Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics (PRE) Q1 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Prenetics Global Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics to Participate in the 38th Annual ROTH Conference
    From Prenetics Global Limited
    Via GlobeNewswire
    The market is filled with gapping stocks in Friday's session. ↗
    Via Chartmill
    News headline image
    Prenetics Authorizes $40 Million Share Repurchase Program
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics Executives Execute Second Consecutive Round of Post-Earnings Open Market Share Purchases of $1.3 Million— Cumulative Personal Investment Across Both Rounds Reaches $2.7 Million
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics Launches IM8 Daily Ultimate Essentials PRO — A Clinical Formula with Two New Flavours
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Formula 1 Phenom Ollie Bearman Joins Prenetics’ IM8 Health as Global Ambassador and Shareholder
    From Prenetics Global Limited
    Via GlobeNewswire
    News headline image
    Prenetics to Report Q4 and Full Year 2025 Financial Results on Feb 18, 2026 and Host Earnings Conference Call
    From Prenetics Global Limited
    Via GlobeNewswire

    Frequently Asked Questions

    Is Prenetics Global Limited - Class A Ordinary Share publicly traded?
    Yes, Prenetics Global Limited - Class A Ordinary Share is publicly traded.
    What exchange does Prenetics Global Limited - Class A Ordinary Share trade on?
    Prenetics Global Limited - Class A Ordinary Share trades on the Nasdaq Stock Market
    What is the ticker symbol for Prenetics Global Limited - Class A Ordinary Share?
    The ticker symbol for Prenetics Global Limited - Class A Ordinary Share is PRE on the Nasdaq Stock Market
    What is the current price of Prenetics Global Limited - Class A Ordinary Share?
    The current price of Prenetics Global Limited - Class A Ordinary Share is 18.67
    When was Prenetics Global Limited - Class A Ordinary Share last traded?
    The last trade of Prenetics Global Limited - Class A Ordinary Share was at 08/03/26 11:57 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.